Broader Portfolio of Recombinant Antibodies Launched by Creative BioMart
Antibodies are vital research tools for cell biology and biomedical research. But it is generally difficult to access high-quality antibodies even with more than 500,000 commercially available antibodies in the market in numerous companies. Creative BioMart develops and screens antibodies with Phage Display and proprietary platforms, which properly ensure the excellent performance with high affinity and specificity.
The antibodies have been available to purchase from Creative BioMart channel. Dr Linna, Commercial Manager at Creative BioMart, commented:
“It is our goal to ensure that we supply the market with antibodies of top world-class performance and help customers to gain more but cost less. We always give customers significant advantages over others. Each antibody is strictly tested and screened to meet the needs. By choosing our recombinant antibodies in a broader range, customers will get more sensitive and reliable results than others, as well as more cost-effective surprises.”
Article Link: Broader Portfolio of Recombinant Antibodies Launched by Creative BioMart
